Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients
Clinical trial NCT04464395 · COMPLETED
Trial details
- NCT number
- NCT04464395
- Sponsor
- Corvus Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-01
- Primary completion
- 2021-03-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.